Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL-ENL, and gene Expression Profiles Determine Obatoclax IC50: A Report on the Children's Oncology Group (COG) P9407 Trial
Year: 2010
Type: article
Source: Blood
Authors: Karen A. Urtishak, Li-San Wang, Richard Harvey, Susan R Atlas, I-Ming L. Chen, Blaine W. Robinson, Lea Moukarzel, Kajia Cao, Meenakshi Devidas, Andrew J. Carroll, Nyla A. Heerema, Stephen Hunger, Gregory H. Reaman, Joanne M. Hilden, Bruce Camitta, Naomi Winick, William L. Carroll, Alena Y. Zhang, Lori Cory, Steven Mc Veigh, Jeffery S. Barrett, Zoann E. Dreyer, Cheryl L. Willman, Carolyn A. Felix
Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, University of New Mexico, UNM Comprehensive Cancer Center, University of Florida Health, University of Florida, University of Alabama at Birmingham, The Ohio State University, University of Colorado Anschutz, Children's National, George Washington University, Peyton Manning Children’s Hospital at St.Vincent, Medical College of Wisconsin, The University of Texas Southwestern Medical Center, NYU Langone Health, New York University, Texas Children's Hospital
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2551992063